FDA, CDC Authorize Pfizer Boosters for 16- and 17-year-olds

The Fda said it was basing its emergency authorization of boosters for 16 and 17 calendar year olds on knowledge from 200 individuals who ended up ages 18 to 55 decades of age when they gained a booster dose. They are demanding Pfizer to obtain information on protection in article-authorization research.